Robin Garner
Stock Analyst at Craig-Hallum
(n/a)
# 2,938
Out of 4,479 analysts
4
Total ratings
n/a
Success rate
-26.75%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Initiates: Buy | $4.5 | $2.06 | +118.45% | 2 | Aug 28, 2023 | |
| CUE Cue Biopharma | Maintains: Buy | $28 → $26 | $1.08 | +2,307.41% | 1 | Mar 18, 2022 | |
| FENC Fennec Pharmaceuticals | Initiates: Buy | n/a | $6.03 | - | 1 | Apr 21, 2021 |
Xeris Biopharma Holdings
Aug 28, 2023
Initiates: Buy
Price Target: $4.5
Current: $2.06
Upside: +118.45%
Cue Biopharma
Mar 18, 2022
Maintains: Buy
Price Target: $28 → $26
Current: $1.08
Upside: +2,307.41%
Fennec Pharmaceuticals
Apr 21, 2021
Initiates: Buy
Price Target: n/a
Current: $6.03
Upside: -